Related Experiment Video

Updated: Jul 15, 2026

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

Double-blind study of lecithin in the treatment of persistent tardive dyskinesia

J Pérez-Cruet, I Menéndez, J Alvarez-Ghersi

    Boletin De La Asociacion Medica De Puerto Rico
    |November 1, 1981
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
    06:45

    Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

    Published on: October 4, 2021

    Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
    05:51

    Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

    Published on: October 14, 2021

    Related Experiment Videos

    Last Updated: Jul 15, 2026

    Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
    08:57

    Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

    Published on: March 26, 2015

    Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
    06:45

    Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

    Published on: October 4, 2021

    Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
    05:51

    Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

    Published on: October 14, 2021

    Related Concept Videos

    Parkinson's Disease: Treatment01:24

    Parkinson's Disease: Treatment

    Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
    Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

    Articles linked to this work by shared authors, journal, and citation graph.

    Variations in Multiple Syndromic Deafness Genes Mimic Non-syndromic Hearing Loss.

    Scientific reports·2016

    A Mayan founder mutation is a common cause of deafness in Guatemala.

    Clinical genetics·2015

    Dengue virus identification by transmission electron microscopy and molecular methods in fatal dengue hemorrhagic fever.

    Infection·2012

    [Comparison between the 1993 and 2002 Guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) for identifying respiratory events in polysomnography tests].

    Archivos de bronconeumologia·2005

    Assembly of truncated HCV core antigen into virus-like particles in Escherichia coli.

    Biochemical and biophysical research communications·2001

    Ultrastructural and immunocytochemical evidences of core-particle formation in the methylotrophic Pichia pastoris yeast when expressing HCV structural proteins (core-E1).

    Tissue & cell·1999

    Factors Associated to Invasive Fungal Infection in Hispanic Patients with Hematological Malignancies.

    Boletin de la Asociacion Medica de Puerto Rico·2018

    Secondary Resistance to dopamine agonist after thirteen months of successful treatment in a 42 years old man.

    Boletin de la Asociacion Medica de Puerto Rico·2017

    Pheochromocytoma in pregnancy: A case Report.

    Boletin de la Asociacion Medica de Puerto Rico·2017

    Acute Shortening and re-lengthening in the management of open tibia fractures with severe bone of 14 CMS or more and extensive soft tissue loss.

    Boletin de la Asociacion Medica de Puerto Rico·2017

    Klinefelter Syndrome (49, XXXXY/48, XXXY) associated with narrow angle glaucoma: A case report.

    Boletin de la Asociacion Medica de Puerto Rico·2017

    Isolated Rectus Femoris Muscle Tear in a Non-Athletic Patient: A Case Report.

    Boletin de la Asociacion Medica de Puerto Rico·2017

    Assessing the use of ASAP-MS for Screening a UK Pub for Illicit Drug Substances.

    Journal of mass spectrometry : JMS·2026

    Angiotensin peptide and aldosterone concentrations in response to four classes of blood-pressure-lowering drugs in hypertensive patients: A randomized trial.

    Journal of human hypertension·2026

    PSMA-targeted radioligand therapy in prostate cancer: evidence hierarchy, platform maturity of ¹⁷⁷Lu-PSMA-617, and the clinical differentiation challenge for emerging radionuclides.

    Annals of nuclear medicine·2026

    Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review.

    Sexual medicine reviews·2026

    Effect of abatacept on bone in patients with psoriatic arthritis-results from a prospective interventional high-resolution imaging study (ABEPSA).

    EULAR rheumatology open·2026

    Contemporary consensus and emerging directions in premature and delayed ejaculation: recommendations from the 5th International Consultation on Sexual Medicine.

    Sexual medicine reviews·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us